|
|
9381 Judicial Drive, Suite 130
San Diego, CA 92121 USA
phone:858.458.8800
fax:858.458.8801 |
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.ceregene.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Genetic therapeutics for the treatment of neurological disorders. |
|
| Management |
| Jeffrey M. Ostrove, Ph.D., President & Chief Executive Officer; Raymond T. Bartus, Ph.D., Executive Vice President & Chief Scientific Officer; Joao Siffert, M.D., Vice President & Chief Medical Officer; Maurice J. Mezzino, C.F.A., Vice President & Chief Business Officer; Kate Van Riper, Senior Director, Human Resources and Administration; Mehdi Gasmi, Ph.D., Senior Director, Product Development; Andrea Loewen-Rodriguez, Senior Director, Regulatory Affairs; Kathie M. Bishop, Ph.D., Director, Preclinical Research & Development; Lisa Ann Melia, Director, Clinical Operations; Carolyn J. Bonebright, Controller |
|
|
| |
|
|
|
|
|
|
| Description |
|
Ceregene's primary focus is the discovery and development of novel genetic therapeutics for the treatment of neurological disorders. Ceregene aims to be the leader in the field of Central Nervous System (CNS) disease treatment using molecular medicine, an area of great unmet medical need. |
|
| Products / Services |
Ceregene's internal focus will be full-scale research and product development efforts in Alzheimer's and Parkinson's diseases using in vivo gene delivery technology.
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
